Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MXCT

Maxcyte (MXCT)

Maxcyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:MXCT
DateTimeSourceHeadlineSymbolCompany
12/23/20241:00AMRNS Regulatory NewsMaxCyte, Inc. MaxCyte Announces Retirement of Board MemberLSE:MXCTMaxcyte Inc
12/19/202410:26AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/18/20249:31AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/10/202411:16AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/10/202411:12AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/09/20246:29AMAlliance NewsAlliance NewsMaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savingsLSE:MXCTMaxcyte Inc
12/09/20241:00AMRNS Regulatory NewsMaxCyte, Inc. MaxCyte Streamlines Operations and Raises GuidanceLSE:MXCTMaxcyte Inc
12/02/202411:09AMRNS Regulatory NewsMaxCyte, Inc. Total Voting Rights and Block Listing ReturnLSE:MXCTMaxcyte Inc
11/28/20249:05AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
11/28/20249:05AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
11/19/20243:49AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
11/08/20248:41AMAlliance NewsAlliance NewsMaxCyte third-quarter profit falls amid surging costsLSE:MXCTMaxcyte Inc
11/07/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Filing of 10Q formLSE:MXCTMaxcyte Inc
11/07/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Third Quarter 2024 Financial ResultsLSE:MXCTMaxcyte Inc
11/06/20243:05PMUK RegulatoryMaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceLSE:MXCTMaxcyte Inc
11/06/20247:43AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
11/04/20247:23AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
10/31/20247:05AMRNS Non-RegulatoryMaxCyte, Inc. Upcoming Investor ConferencesLSE:MXCTMaxcyte Inc
10/31/20242:00AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
10/18/20243:24AMRNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
10/15/20247:05AMRNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Cynthia Collins to BoardLSE:MXCTMaxcyte Inc
10/11/20247:00AMRNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
10/10/20247:05AMRNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCOLSE:MXCTMaxcyte Inc
10/03/20243:41AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
10/01/20243:47AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
10/01/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
09/27/202410:15AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/27/20249:29AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/20/202411:02AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/16/20244:33AMAlliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCT